BARDA is providing a portal for the U.S. government 2019 novel coronavirus (2019-nCoV) medical countermeasures task
force to provide a single point of entry for the submission of market research packages from interested stakeholders.
At this time, we ask for a very brief (500-word) description of your product or technology, accompanied by a brief white paper, slide deck, manuscript, or other non-confidential information of your choosing. Please note that while we will use any information you present as market research, submission is no guarantee of funding and your submission will be shared across U.S. Government agencies involved in nCoV medical countermeasure research and development.
Ideal technologies and products would (but are not required to) be:
- Relevant to the U.S. government nCoV medical countermeasure research and development efforts and/or Emerging Infectious Disease rapid response capabilities
- Utilize an already-approved platform, have non-clinical data suggesting efficacy, and/or have significant manufacturing capability
- Fully owned or licensed by your organization (you have full IP rights and/or freedom to operate)
Submission of a market research package is not a guarantee of government funding. Submissions should not be directly related to any active BARDA or other USG solicitation (that is, a formally submitted response to our BAA, EZ BAA, or another RFP) unless BARDA Contracting expressly states that such a submission is acceptable.